Zinc supplementation decreases the development of atherosclerosis in rabbits

Free Radical Biology and Medicine

Volumn 41, Issue 2, 2006, Pages 222-225

  Ren, Minqin ^a,b   Rajendran, Reshmi ^a,b   Ning, Pan ^b   Tan Kwong Huat, Benny ^b   Choon Nam, Ong ^b   Watt, Frank ^a   Jenner, Andrew ^b   Halliwell, Barry ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Atherosclerosis; Free radicals; Iron; Lesion area; Nuclear microscopy; Zinc; Zinc supplement

Indexed keywords

FREE RADICAL; IRON; ZINC CARBONATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHEMICAL REACTION; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG EFFECT; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUPPLEMENTATION; TISSUE SECTION;

ANIMALS; ATHEROSCLEROSIS; DIETARY SUPPLEMENTS; MALE; RABBITS; ZINC;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 33745233825     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.03.017     Document Type: Article

References (24)

1. Smith C., Mitchinson M.J., Aruoma O.I., and Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem. J. 286 (1992) 901-905
2. Giles W.H., Anda R.F., Williamson D.F., Yip R., and Marks J. Iron and ischemic heart disease. Circulation 87 (1993) 2065-2066
3. Matthews A.J., Vercellotti G.M., and Menchaca H.J. Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1). J. Surg. Res. 73 (1997) 35-40
4. Stadler N., Lindner R.A., and Davies M.J. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 949-954
5. Sullivan J.L. Iron and the sex difference in heart disease risk. Lancet 1 (1981) 1293-1294
6. Watt F., Ren M.Q., Xie J.P., Tan B.K.H., and Halliwell B. Nuclear microscopy of atherosclerotic tissue: a review. Nucl. Instrum. Methods B 181 (2001) 431-436
7. Ponraj D., Makjanic J., Thong P.S.P., Tan B.K.H., and Watt F. The onset of atherosclerotic lesion formation in hypercholesterolemic rabbits is delayed by iron depletion. FEBS Lett. 459 (1999) 218-222
8. Halliwell B. Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action?. Free Radic. Biol. Med. 7 (1989) 645-651
9. Ren M.Q., Rajendran R., Pan N., Tan B.K.-H., Ong W.-Y., Watt F., and Halliwell B. The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit. Free Radic. Biol. Med. 38 (2005) 1206-1211
10. Ren M.Q., Watt F., Tan K.W., and Halliwell B. Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions. Free Radic. Biol. Med. 34 (2003) 746-752
11. Halliwell, B.; Gutteridge, J.M.C. Free radicals in biology and medicine, (fourth ed). Oxford: Clarendon; in press.
12. Girotti A.W., Thomas J.P., and Jordan J.E. Inhibitory effect of Zn(II) on free radical lipid peroxidation in erythrocyte membranes. Free Radic. Biol. Med. 1 (1985) 395-401
13. Zago M.P., and Oteiza P.I. The anti-oxidant properties of zinc: interactions with iron and antioxidants. Free Radic. Biol. Med. 31 (2001) 266-274
14. Meerarani P., Ramadass P., Toborek M., Bauer H.C., Bauer H., and Hennig B. Zinc protects against apoptosis of endothelial cells induced by linoleic acid and tumor necrosis factor α. Am. J. Clin. Nutr. 71 (2000) 81-87
15. Hennig B., Meeranani P., Toborek M., and McClain C.J. Antioxidant like properties of zinc in activated endothelial cells. J. Am. Coll. Nutr. 18 (1999) 152-158
16. Hennig B., and Torobeck M. Nutrition and endothelial cell function: implications in atherosclerosis. Nutr. Res. 21 (2001) 279-293
17. Berger M., Rubinraut E., Barshack I., Roth A., Keren G., and George J. Zinc reduces intimal hyperplasia in the rat carotid injury model. Atherosclerosis 175 (2004) 229-334
18. Reiterer G., Toborek M., and Hennig B. Peroxisome proliferator activated receptors α and γ require zinc for their anti-inflammatory properties in porcine vascular endothelial cells. J. Nutr. 34 (2004) 1711-1715
19. McClain C., Morris P., and Hennig B. Zinc and endothelial function. Nutrition 11 (1995) 117-120
20. Hennig B., Meeranani P., Ramadass P., Toborek M., Malecki A., Slim R., and McClain C.J. Zinc nutrition and apoptosis of vascular endothelial cells: implications in atherosclerosis. Nutrition 15 (1999) 744-748
21. Gatto L.M., and Samman S. The effect of zinc supplementation on plasma lipids and low density lipoprotein oxidation on males. Free Radic. Biol. Med. 19 (1995) 517-521
22. Wilkins G.M., and Leake D.S. The oxidation of low density lipoprotein by cells or iron is inhibited by zinc. FEBS Lett. 341 (1994) 259-262
23. Bray T.M., and Bettger W.J. The physiological role of zinc as an antioxidant. Free Radic. Biol. Med. 8 (1990) 181-291
24. Hennig B., Toborek M., and McClain C.J. Antiatherogenic properties of zinc: implications in endothelial cell metabolism. Nutrition 12 (1996) 711-717